The First and Only FDA-Authorized Treatment for Dry-Age Related Macular Degeneration (AMD) to Improve Vision

Valeda delivers a non-invasive, multiwavelength, light-based therapy that utilizes photobiomodulation (PBM) to treat dry age-related macular degeneration (AMD). Clinical studies have shown that Valeda can improve visual outcomes.

Assessment & Treatment Course

At the initial assessment, a routine retinal examination with imaging is performed to verify that you are suitable for treatment. Follow-up retinal examinations with imaging will occur following your last treatment in each cycle.

Treatment typically consists of three cycles annually, four months apart. Nine treatment sessions spread over a 3-5-week period typically make up one treatment cycle.

Treatment lasts less than five minutes on each eye. The treatment is safe, non-invasive, and generally pain free. There is no down-time required following treatment.

A follow-up retinal examination with imaging is performed after your last treatment in each cycle.

Does Insurance Cover Valeda?

Valeda is not covered by insurance; however, you may be eligible for reimbursement through your Flexible Spending Account (FSA) or Health Savings Account (HSA). Please contact your insurance provider or FSA/HSA administrator for additional information.